Federated-learning healthcare AI. Closed a 2026 H1 round for trial-acceleration platform and oncology programs.
From Wikipedia
Owkin is a French-American artificial intelligence and biotech company that aims to identify new treatments, optimize clinical trials and develop AI diagnostics. The company uses multimodal patient data from academic institutions and hospitals to train its AI models for drug discovery, development, and diagnostics. Owkin has collaborated with pharmaceutical companies around the world to improve their therapeutic programs.